{"name": "Cerenis Therapeutics",
 "permalink": "cerenis-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/cerenis-therapeutics",
 "homepage_url": "http://www.cerenis.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cerenis.com",
 "phone_number": "+33 (0) 5 62 24 97 06",
 "description": "",
 "created_at": "Tue Jul 27 02:18:02 UTC 2010",
 "updated_at": "Wed Nov 24 02:12:41 UTC 2010",
 "overview": "\u003Cp\u003ECerenis Therapeutics is a multinational biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       64],
      "assets/images/resized/0010/6866/106866v1-max-150x150.png"],
     [[191,
       82],
      "assets/images/resized/0010/6866/106866v1-max-250x250.png"],
     [[191,
       82],
      "assets/images/resized/0010/6866/106866v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Jean-Louis",
      "last_name": "Dasseux",
      "permalink": "jean-louis-dasseux",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "William",
      "last_name": "Brinkerhoff",
      "permalink": "william-brinkerhoff",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac60.7M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "http://www.cerenis.com/media-detail.asp?id=252",
    "source_description": "Cerenis Therapeutics and Novasep awarded EUR 10.7 million funding from the French Government for the development CER-001, an HDL mimetic",
    "raised_amount": 10700000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 26,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.cerenis.com/media-detail.asp?id=253",
    "source_description": "Cerenis Therapeutics raises EUR 40 million in series C financing",
    "raised_amount": 40000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "French Strategic Investment Funds",
         "permalink": "french-strategic-investment-funds",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TVM Capital",
         "permalink": "tvm-capital",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0003/0797/30797v1-max-150x150.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-250x250.png"],
             [[221,
               53],
              "assets/images/resized/0003/0797/30797v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "EDF Ventures",
         "permalink": "edf-ventures",
         "image":
          {"available_sizes":
            [[[136,
               53],
              "assets/images/resized/0002/8458/28458v1-max-150x150.png"],
             [[136,
               53],
              "assets/images/resized/0002/8458/28458v1-max-250x250.png"],
             [[136,
               53],
              "assets/images/resized/0002/8458/28458v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.cerenis.com/media-detail.asp?id=260",
    "source_description": "Cerenis Therapeutics raises additional \u00e2\u201a\u00ac10 million to close \u00e2\u201a\u00ac50 million Series C financing",
    "raised_amount": 10000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "IXO Private Equity",
         "permalink": "ixo-private-equity",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "BP 87519",
    "address2": "Rue de la D\u00c3\u00a9couverte",
    "zip_code": "31675 ",
    "city": "LABEGE cedex",
    "state_code": null,
    "country_code": "FRA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}